Alchemia is a biotechnology company. The Company is engaged in developing new human therapeutics based on its proprietary drug discovery, dry targeting and synthesis technologies. The Company specializes in two areas, clinical development of targeted cancer therapies and the discovery and development of novel drugs based on its proprietary capabilities in complex chemical syntheses.Data provided by Mergent, Inc.
|Effective Date||Nov 03, 2004|
|Industry||Pharma. & Biotech.|